nancy lynn snyderman MD

nancy lynn snyderman MD, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Alkermes plc., Axonics, Inc. and Future Health ESG Corp. The record holds 29 filings, for trades running from 8 April 2019 to 3 August 2026.

On the open market, the record shows 3 purchases worth €83k and 1 sale worth €1.9M. Taken together, the sales exceed the purchases by €1.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants and 9 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €9,040.

Most recently, on 3 August 2026, the filings show an option exercise worth €669k in Alkermes plc. The most recent open-market purchase was published on 8 March 2022, 1,691 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.